Sodium bicarbonate for kidney disease energy and acidity
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether taking sodium bicarbonate changes “energy” in cells and improves metabolic acidosis (an acid build-up) in people with moderate-to-severe chronic kidney disease. You may be able to join if your kidney function and blood bicarbonate levels fit their targets and you meet safety rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic kidney disease with eGFR under 50 at least twice
- You have low blood bicarbonate suggesting ongoing metabolic acidosis
- You are between 21 and 85 years old
- You do not have certain major health exclusions (like type 1 diabetes or uncontrolled blood pressure)
- You must be able to consent and communicate in English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking sodium bicarbonate tablets by mouth can help correct low bicarbonate levels in people on hemodialysis, compared to using higher bicarbonate in the dialysis fluid. It aims to find a safer and more effective way to treat metabolic acidosis, a common condition in dialysis patients.
This trial tests if giving sodium bicarbonate helps critically ill patients who have both metabolic acidosis (too much acid in the blood) and acute kidney injury (sudden kidney trouble). It aims to see if this treatment can improve outcomes.
This study tests a type of dialysis that uses different levels of bicarbonate to see if it can improve health for people with kidney failure. It may help patients who are already on regular dialysis.
This trial tests whether adding an “alkali” treatment (to raise low blood bicarbonate) can improve blood vessel and kidney graft function in people whose kidney transplant is about 1 year old. It may help if you have lower-than-normal bicarbonate levels while on stable transplant and blood pressure medicines.
This study tests an oral medicine called Veverimer to see if it safely corrects low bicarbonate levels (metabolic acidosis) in people with chronic kidney disease. It might help you feel better and protect your kidneys.
This Phase 2 study tests whether atorvastatin plus an “alkalizing” treatment (sodium bicarbonate) can slow or improve disease effects in people with autosomal dominant polycystic kidney disease (ADPKD). It specifically targets metabolic acidosis (when the body becomes “too acidic”), which may worsen kidney health.
Hear when a new Metabolic Acidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.